Dr. Kizzmekia Corbett was born in Hurdle Hills, NC, in 1986. Her earliest signs of brilliancy were when her fourth-grade teacher, Myrtis Bradsher, recognized Corbett's potential and talent at an early age and encouraged Kizzy's mother to place her in advanced classes. "I always thought she is going to do something one day. She dotted i's and crossed t's. The best in my 30 years of teaching," Bradsher said in a 2020 interview with The Washington Post.
I recommend she take advanced classes.
Your daughter is a beyond excellent student! She understands the material quickly and is much more advanced for her age.
Corbett had been interested in science from a young age, she was given the opprotunity to attend the University of Maryland as a Meyerhoff Scholar, a challenging program that mentors minorities and women in science. Progams like these help include more women and minorities in science fields as they make up a small percentage. In 2008, she recieved a B.S. in sociology from the University of Maryland. In 2014, Corbett received a PhD in microbiology and immunology from the University of North Carolina at Chapel Hill. For her doctoral work, Corbett worked in Sri Lanka to study the role of human antibodies in dengue virus pathogenesis.
Dr. Kizzmekia Corbett is an example of someone who can represent a minority group in a field as major as science. It is essential that kind and hard working people such as Dr. Corbett are found working in the field in order to inspire others who are just like her to follow in her foot steps and become the next generation of impactful scientists. Her research aimed to uncover the mechanisms of viral pathogenesis and host immunity.
As Covid case numbers skyrocketed, Corbett began work on a vaccine that would protect the public from the virus. She was able to recognize the similarities that the virus shared to severe acute respiratory syndrome coronavirus, Corbett's team made use of previous knowledge about coronavirus S proteins in order to fight against Covid-19. As Covid case numbers skyrocketed, Corbett began work on a vaccine that would protect the public from the virus.
My prior research suggests that encoding S protein could be used to excite the immune response to produce protective antibodies against coronavirus disease!
Spike Proteins
There is a lot of specullation and distrust when it comes to Covid-19 vaccines, but scientist such as Dr. Kizzmekia Corbett are showing the public the truth and nothing but the truth. In collaboration with Moderna, Dr. Kizzmekia Corbett was at the forefront for developing a vaccine that would be able to be used against Covid-19. The technique the vaccine employed was teaching the human body to recognize the spike proteins on the virus and fight against it.
In collaboration with Moderna, Cobertt, and her team rapidly entered animal testing trials before they could conduct any on people. Afterwards, the vaccine entered Phase 1 clinical trial only 66 days after the virus sequence was released. The trial had to be completed in at least 45 people, is a dose-escalation study in the form of two injections done 28 days apart.